Literature DB >> 25897779

Exploiting metal-ligand bifunctional reactions in the design of iron asymmetric hydrogenation catalysts.

Robert H Morris1.   

Abstract

This is an Account of our development of iron-based catalysts for the asymmetric transfer hydrogenation (ATH) and asymmetric pressure hydrogenation (AH) of ketones and imines. These chemical processes provide enantiopure alcohols and amines for use in the pharmaceutical, agrochemical, fragrance, and other fine chemical industries. Fundamental principles of bifunctional reactivity obtained by studies of ruthenium catalysts by Noyori's group and our own with tetradentate ligands with tertiary phosphine and secondary amine donor groups were applied to improve the performance of these first iron(II) catalysts. In particular the correct positioning of a bifunctional H-Fe-NH unit in an iron hydride amine complex leads to exceptional catalyst activity because of the low energy barrier of dihydrogen transfer to the polar bond of the substrate. In addition the ligand structure with this NH group along with an asymmetric array of aryl groups orients the incoming substrate by hydrogen-bonding, and steric interactions provide the hydrogenated product in high enantioselectivity for several classes of substrates. Enantiomerically pure diamines or diphenylphosphino-amine compounds are used as the source of the asymmetry in the tetradentate ligands formed by the condensation of the amines with dialkyl- or diaryl-phosphinoaldehydes, a synthesis that is templated by Fe(II). The commercially available ortho-diphenylphosphinobenzaldehyde was used in the initial studies, but then diaryl-phosphinoacetaldehydes were found to produce much more effective ligands for iron(II). Once the mechanism of catalysis became clearer, the iron-templated synthesis of (S,S)-PAr2CH2CH2NHCHPhCHPhNH2 ligand precursors was developed to specifically introduce a secondary amine in the precatalyst structures. The reaction of a precatalyst with strong base yields a key iron-amido complex that reacts with isopropanol (in ATH) or dihydrogen (in AH) to generate an iron hydride with the Fe-H bond parallel to the secondary amine N-H. In the AH reactions, the correct acidity of the intermediate iron-dihydrogen complex and correct basicity of the amide are important factors for the heterolytic splitting of the dihydrogen to generate the H-Fe-N-H unit; the acidity of dihydrogen complexes including those found in hydrogenases can be estimated by a simple additive ligand acidity constant method. The placement of the hydridic-protonic Fe-H···HN interaction in the asymmetric catalyst structure influences the enantioinduction. The sense of enantioinduction is predictable from the structure of the H-Fe-N-H-containing catalyst interacting with the ketone in the same way as related H-Ru-N-H-containing catalysts. The modular construction of the catalysts permits large variations in order to produce alcohol or amine products with enantiomeric excess in the 90-100% range in several cases.

Entities:  

Year:  2015        PMID: 25897779     DOI: 10.1021/acs.accounts.5b00045

Source DB:  PubMed          Journal:  Acc Chem Res        ISSN: 0001-4842            Impact factor:   22.384


  32 in total

Review 1.  Frustration across the periodic table: heterolytic cleavage of dihydrogen by metal complexes.

Authors:  R Morris Bullock; Geoffrey M Chambers
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2017-08-28       Impact factor: 4.226

2.  An iron(ii) hydride complex of a ligand with two adjacent β-diketiminate binding sites and its reactivity.

Authors:  Henrike Gehring; Ramona Metzinger; Beatrice Braun; Christian Herwig; Sjoerd Harder; Kallol Ray; Christian Limberg
Journal:  Dalton Trans       Date:  2016-01-13       Impact factor: 4.390

3.  Cooperative Activation of CO2 and Epoxide by a Heterobinuclear Al-Fe Complex via Radical Pair Mechanisms.

Authors:  Soumen Sinhababu; Maxim R Radzhabov; Joshua Telser; Neal P Mankad
Journal:  J Am Chem Soc       Date:  2022-02-14       Impact factor: 16.383

4.  A Unified Treatment of the Relationship Between Ligand Substituents and Spin State in a Family of Iron(II) Complexes.

Authors:  Laurence J Kershaw Cook; Rafal Kulmaczewski; Rufeida Mohammed; Stephen Dudley; Simon A Barrett; Marc A Little; Robert J Deeth; Malcolm A Halcrow
Journal:  Angew Chem Int Ed Engl       Date:  2016-03-01       Impact factor: 15.336

5.  Ruthenium PNN(O) Complexes: Cooperative Reactivity and Application as Catalysts for Acceptorless Dehydrogenative Coupling Reactions.

Authors:  Sandra Y de Boer; Ties J Korstanje; Stefan R La Rooij; Rogier Kox; Joost N H Reek; Jarl Ivar van der Vlugt
Journal:  Organometallics       Date:  2017-04-06       Impact factor: 3.876

6.  Nickel-catalyzed asymmetric hydrogenation of β-acylamino nitroolefins: an efficient approach to chiral amines.

Authors:  Wenchao Gao; Hui Lv; Tonghuan Zhang; Yuhong Yang; Lung Wa Chung; Yun-Dong Wu; Xumu Zhang
Journal:  Chem Sci       Date:  2017-07-04       Impact factor: 9.825

7.  Ligand Substitution and Electronic Structure Studies of Bis(phosphine)Cobalt Cyclooctadiene Precatalysts for Alkene Hydrogenation.

Authors:  Hongyu Zhong; Megan Mohadjer Beromi; Paul J Chirik
Journal:  Can J Chem       Date:  2020-09-28       Impact factor: 1.118

8.  Catalytic asymmetric hydrogenation of (Z)-α-dehydroamido boronate esters: direct route to alkyl-substituted α-amidoboronic esters.

Authors:  Yazhou Lou; Jun Wang; Gelin Gong; Fanfu Guan; Jiaxiang Lu; Jialin Wen; Xumu Zhang
Journal:  Chem Sci       Date:  2019-11-25       Impact factor: 9.825

9.  Iron-based nanocatalyst for the acceptorless dehydrogenation reactions.

Authors:  Garima Jaiswal; Vinod G Landge; Dinesh Jagadeesan; Ekambaram Balaraman
Journal:  Nat Commun       Date:  2017-12-15       Impact factor: 14.919

10.  Unprecedented selective homogeneous cobalt-catalysed reductive alkoxylation of cyclic imides under mild conditions.

Authors:  Jose R Cabrero-Antonino; Rosa Adam; Veronica Papa; Mattes Holsten; Kathrin Junge; Matthias Beller
Journal:  Chem Sci       Date:  2017-06-12       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.